Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04390763 |
|---|---|
| Brief Title: | Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) |
| First Submitted : | May 14, 2020 |
| First Submitted that Met QC Criteria : | May 14, 2020 |
| First Posted : | May 18, 2020 |
| Last Update Submitted that Met QC Criteria : | December 14, 2020 |
| Last Update Posted : | December 16, 2020 |